Answers are grounded in this paper and cite their sources.
Review highlights advances in mesoporous silica nanoparticles for targeted cancer therapy, indicating machine learning enhances formulation efficiency despite persistent translational barriers.
Mesoporous silica nanoparticles (MSNs) are becoming popular for targeted drug delivery because their pore structure can be changed, they have a large surface area, and their surface can be easily modified. This review critically assesses recent advancements in MSN-based drug delivery systems, emphasizing the structure–property–performance relationships that affect drug loading, release kinetics, and targeting efficiency, particularly in cancer therapy. We emphasize the increasing significance of data-driven and machine learning (ML) techniques in enhancing MSN synthesis and functionalization, transcending conventional design methodologies. Machine learning (ML) models have shown promise in improving predictive accuracy, reproducibility, and formulation efficiency by linking multidimensional synthesis parameters with physicochemical properties and therapeutic outcomes. We conduct a thorough examination of comparative studies concerning stimulus-responsive systems, co-delivery platforms, and theranostic MSNs, while pinpointing significant constraints related to biosafety, pharmacokinetics, scalability, and clinical translation. Finally, we talk about the problems that ML-assisted MSN design and getting regulatory approval are having right now and what could happen in the future. We regard MSNs as promising candidates for precision nanomedicine rather than as solutions that have attained clinical maturity.
No takes yet. Share an insight, caveat, or question.
Khoz et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: